Scientists from Sanford Burnham Prebys have created natural-looking hair that grows through the skin using human induced pluripotent stem cells (iPSCs), a major scientific achievement that could revolutionize the hair growth industry. The findings were presented today at the annual meeting of the International Society for Stem Cell Research (ISSCR) and received a Merit Award. A newly formed company, Stemson Therapeutics, has licensed the technology.
More than 80 million men, women and children in the United States experience hair loss. Genetics, aging, childbirth, cancer treatment, burn injuries and medical disorders such as alopecia can cause the condition. Hair loss is often associated with emotional distress that can reduce quality of life and lead to anxiety and depression.
“Our new protocol described today overcomes key technological challenges that kept our discovery from real-world use,” says Alexey Terskikh, Ph.D., an associate professor in Sanford Burnham Prebys’ Development, Aging and Regeneration Program and the co-founder and chief scientific officer of Stemson Therapeutics. “Now we have a robust, highly controlled method for generating natural-looking hair that grows through the skin using an unlimited source of human iPSC-derived dermal papilla cells. This is a critical breakthrough in the development of cell-based hair-loss therapies and the regenerative medicine field.”
An all-star panel of experts in nutritional studies with an emphasis on longevity. At some point in your life, you have heard the following. “Eat the right food. It will help you live longer.” What if I told you the right food could help you heal as well. This panel of longevity driven nutritionist will give you a broad range of fact-based regiments and compelling individual opinions on Nutrition and longevity. This segment will cover many diverse understandable methods that can make a change in longevity for you or your loved ones. Fill yourself with the knowledge of proper nutrition for longevity.
Speakers Will Include: Brian Clement – Plant-Based & founder of “Hippocrates Health Institute” A typical American growing up in the New Jersey/New York area, Brian likes to joke that he was a pioneer in the field of obesity—he was fat even before many Americans were fat! Raised in an Irish household on the standard American diet of meat, processed foods, and sugary sodas, he was unfit and gasping for air every few steps. When he was 20 years old, he was dating a girl whose best friend’s boyfriend was 30—and a vegetarian. Despite the fact he had been more or less educated by his family that the body would die without animal-based foods, the lure of an influential peer inspired him to give up meat in one fell swoop. For the first year and a half, he kept his vegetarian diet a secret from his family. Yet after losing 120 pounds and experiencing the difference in his health, he came out of the proverbial closet (much to his family’s dismay!) and became a complete vegan three years later.
Wendi Blum – Founder of “Founder of Create Your Best Life” Wendi Blum worked in the pharmaceutical industry for over 20 years until (at age 45) felt a calling to completely change every aspect of her life. After two decades in a successful sales career (having worked for Zenecca Pharmaceuticals, PDI and Bristol Myers Squibb, wearing many different hats including advocacy, sales, and training) Wendi decided to re-write the story of her life literally and become an international inspirational speaker, author, workshop leader, success coach, and life-shift retreat guru. She is the author of 5 books – known for her focus on reinvention, goal mastery, and business savvy – she is known as “the queen of reinvention” Her titles include: “Your Life, Your Destiny, Uncover Yours, LifeShift” and “Goals Setting Workbook: Success Strategies for The New Economy” – and many more. Blum is known for her blend of Spiritual flare with business savvy” because of how she merges these two powerful components together.
Bill Faloon — Director and Co-founder of the “Life Extension Foundation”.
Bill Faloon compiled the 1,500-page medical reference book Disease Prevention and Treatment, and his latest book is Pharmocracy: How Corrupt Deals and Misguided Medical Regulations Are Bankrupting America—and What to Do About It. He is also director and co-founder of the Life Extension Foundation, a consumer advocacy organization that funds research and disseminates information to consumers about optimal health. Mr. Faloon has made hundreds of media appearances, including guest spots on The Phil Donohue Show, Tony Brown’s Journal, and ABC News Day One, and has been interviewed Newsweek and other magazines.
There are certain enzymes — proteins — plaques that help cause Alzheimer’s, just recently in fact {which I as most could have told them} the gut microbes and mouth microbes are found to assist in Dementia and Alzheimers. But I and Hippocrates as others have been declaring that fact for quite some time… Respect AEWR wherein the amazing gathered data of mankind has yielded the many causes and a cure for aging…
For decades, research into Alzheimer’s has made slow progress, but now a mother and daughter team think they have finally found a solution – a vaccine that could inoculate potential sufferers.
Sydney — Post-mortem examinations have found a degenerative brain disease linked to repeated blows to the head in two elite Australian rugby league players, the first cases found in the sport, researchers said on Thursday.
The researchers said the players both had chronic traumatic encephalopathy (CTE), which has been widely diagnosed among former US National Football League (NFL) players but is little studied elsewhere.
The Sydney-based study said the condition, once known as ‘punch drunk syndrome’ occurred when repeated brain trauma led to a long-term decline in cognitive function.
Nano Lett. 2017 Sep 13;17:5836–5842. doi: 10.1021/acs.nanolett.7b03081. Epub 2017 Aug 14.
Syringe-injectable mesh electronics represent a new paradigm for brain science and neural prosthetics by virtue of the stable seamless integration of the electronics with neural tissues, a consequence of the macroporous mesh electronics structure with all size features similar to or less than individual neurons and tissue-like flexibility. These same properties, however, make input/output (I/O) connection to measurement electronics challenging, and work to-date has required methods that could be difficult to implement by the life sciences community. Here we present a new syringe-injectable mesh electronics design with plug-and-play I/O interfacing that is rapid, scalable, and user-friendly to nonexperts. The basic design tapers the ultraflexible mesh electronics to a narrow stem that routes all of the device/electrode interconnects to I/O pads that are inserted into a standard zero insertion force (ZIF) connector.
It sounds like something a wild-eyed basement-dweller would come up with, after he complained about the fit of his tinfoil hat. But military bureaucrats really are asking scientists to help them “degrade enemy performance” by attacking the brain’s “chemical pathway[s].” Let the conspiracy theories begin.
You’ve read your last complimentary article this month. To read the full article, SUBSCRIBE NOW. If you’re already a subscriber, please sign in and and verify your subscription.
Researchers at the Johns Hopkins University School of Medicine, in Baltimore, MD, conducted their investigation in a new mouse model of Parkinson’s disease.
The new model replicates a number of early and late signs and symptoms of Parkinson’s disease, including some that are not movement-related.
Individuals that are experiencing frequent migraines, may soon receive access to a new class of medications.
A pair of large studies showed that two drugs have the ability to reduce the frequency of the migraine attacks, without any side effects. The researchers report in the New England Journal of Medicine that the drugs offer the first ever migraine treatment that is aimed at the disorder itself, instead of the symptoms.
Current migraine treatments consist of drugs that are designed to treat epilepsy, depression and high blood pressure. Peter Goadsby, an author of one of the studies in question and a professor at King’s College in London says that they give the patients a choice between antidepressants that will make them sleepy, and a beta blocker, which will make them feel tired.
